Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%

The angiotensin-receptor-neprilysin inhibitor (ARNI) reduced cardiovascular deaths and heart failure hospitalization in patients with heart failure of reduced ejection fraction (HFrEF). Its role in non-HFrEF patients was not clear. This study aims to answer this question. In this retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingyue, Xin, Yanguo, Li, Junli, Cao, Xiaofan, Liu, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775387/
https://www.ncbi.nlm.nih.gov/pubmed/31574852
http://dx.doi.org/10.1097/MD.0000000000017296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775387/
https://www.ncbi.nlm.nih.gov/pubmed/31574852
http://dx.doi.org/10.1097/MD.0000000000017296

Ejemplares similares